Home / Resources / Videos / ADA 2018 / Tim Dunn 2018 Complete Interview

Tim Dunn 2018 Complete Interview

Diabetes in Control speaks with top endocrinologists and other medical professionals to bring you the latest in diabetes news and research. This week, we have another exclusive interview from the ADA 2018  in Orlando.

Tim Dunn, Ph.D., is the director of Clinical and Computational Research and an Abbott Volwiler Research Fellow.  He also serves as Chair of the Scientific Research Review Committee for investigator-initiated studies. His major areas of expertise are clinical trial strategy and trial design and real-world data analysis.


Tim joined Abbott in 2006, and has held previous positions as a Senior Systems Engineer and Abbott Volwiler Associate Research Fellow. During this time, he focused on products for people with diabetes and their care providers, with an expertise in signal processing, system design, and clinical research data analysis.

Dr. Dunn earned his doctorate in bioengineering from the Joint Graduate Group in Bioengineering at University of California Berkeley and University of California San Francisco, received a Management of Technology certificate from the Haas School of Business, and was an ARCS Scholar 2001-2003. His undergraduate degree from Brown University in biomedical engineering was awarded with honors. Prior to graduate school, he was a research engineer with Cygnus, as a team member that developed the first continuous, non-invasive glucose monitoring device to receive Food and Drug Administration clearance.  He has authored or co-authored more than 16 scientific peer-reviewed publications, 36 conference proceedings, and been granted 27 patents.

Featured videos include:

Pt.1: FreeStyle Libre CGM

Pt.2: Using a CGM as a Diabetes Treatment

Pt.3: The High Cost of a CGM

Pt.4: Data On Youth Usage

Pt.5: Software for Viewing CGM Information

Pt.6: Final Thoughts and CGM Availability

or view the complete interview here: Full Interview.

To read the transcript of the full interview, click here.